FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553524991> ?p ?o ?g. }

• W2553524991 endingPage "169" @default.
• W2553524991 startingPage "160" @default.
• W2553524991 abstract "PurposeTo evaluate the quality of life (QoL) in patients with quiescent herpes simplex keratitis compared with control patients without ocular herpes.DesignProspective, case-control study.ParticipantsThirty-three patients with a unilateral and relapsing herpes simplex keratitis (HSK group) that was quiescent during evaluation (no acute episode in the past 3 months) and 66 patients with no history of HSK (control group). Both groups were age and gender matched.MethodsThree previously validated QoL questionnaires were used in this study: the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25), Glaucoma Quality of Life 17 (Glau-QoL17) questionnaire, and Ocular Surface Disease Quality of Life (OSD-QoL) questionnaire. Each questionnaire covered various aspects of the disease.Main Outcome MeasuresThe outcomes of the 3 questionnaires were compared between groups. For the HSK group, the results were correlated to the clinical findings and the history of herpetic disease.ResultsThe mean total questionnaire scores of the 3 QoL questionnaires were significantly lower in the HSK group compared with controls (NEI VFQ-25: 70.5±3.8 vs. 91.1±0.8, P < 0.0001; Glau-QoL17: 68.2±3.1 vs. 87.9±1.0, P < 0.0001; and OSD-QoL: 65.4±2.9 vs. 93.1±0.6, P < 0.0001, respectively). In the HSK group, the level of visual acuity (VA) in the affected eye had the greatest impact on QoL, inducing lower QoL results related to “general vision,” “distance activities,” “dependency,” “peripheral vision,” “self-image,” “daily living,” and “driving” dimensions. Decreased VA in the unaffected eye also negatively affected “self-image” and “driving” results. Patients with frequent HSK relapses had lower QoL related to “ocular pain” and “acknowledgement.”ConclusionsEven during a quiescent phase of the disease, unilateral and relapsing HSK significantly impairs the QoL of patients to a similar level as most sight-threatening diseases. The decrease of VA has the greatest overall effect, but other factors also significantly affect QoL, such as the frequency of relapses. To evaluate the quality of life (QoL) in patients with quiescent herpes simplex keratitis compared with control patients without ocular herpes. Prospective, case-control study. Thirty-three patients with a unilateral and relapsing herpes simplex keratitis (HSK group) that was quiescent during evaluation (no acute episode in the past 3 months) and 66 patients with no history of HSK (control group). Both groups were age and gender matched. Three previously validated QoL questionnaires were used in this study: the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25), Glaucoma Quality of Life 17 (Glau-QoL17) questionnaire, and Ocular Surface Disease Quality of Life (OSD-QoL) questionnaire. Each questionnaire covered various aspects of the disease. The outcomes of the 3 questionnaires were compared between groups. For the HSK group, the results were correlated to the clinical findings and the history of herpetic disease. The mean total questionnaire scores of the 3 QoL questionnaires were significantly lower in the HSK group compared with controls (NEI VFQ-25: 70.5±3.8 vs. 91.1±0.8, P < 0.0001; Glau-QoL17: 68.2±3.1 vs. 87.9±1.0, P < 0.0001; and OSD-QoL: 65.4±2.9 vs. 93.1±0.6, P < 0.0001, respectively). In the HSK group, the level of visual acuity (VA) in the affected eye had the greatest impact on QoL, inducing lower QoL results related to “general vision,” “distance activities,” “dependency,” “peripheral vision,” “self-image,” “daily living,” and “driving” dimensions. Decreased VA in the unaffected eye also negatively affected “self-image” and “driving” results. Patients with frequent HSK relapses had lower QoL related to “ocular pain” and “acknowledgement.” Even during a quiescent phase of the disease, unilateral and relapsing HSK significantly impairs the QoL of patients to a similar level as most sight-threatening diseases. The decrease of VA has the greatest overall effect, but other factors also significantly affect QoL, such as the frequency of relapses." @default.
• W2553524991 created "2016-11-30" @default.
• W2553524991 creator A5020600237 @default.
• W2553524991 creator A5021915992 @default.
• W2553524991 creator A5028366362 @default.
• W2553524991 creator A5035292611 @default.
• W2553524991 creator A5052865753 @default.
• W2553524991 creator A5064803314 @default.
• W2553524991 date "2017-02-01" @default.
• W2553524991 modified "2023-10-18" @default.
• W2553524991 title "Persistent Impairment of Quality of Life in Patients with Herpes Simplex Keratitis" @default.
• W2553524991 cites W1537646782 @default.
• W2553524991 cites W1546655223 @default.
• W2553524991 cites W1922329869 @default.
• W2553524991 cites W1969418377 @default.
• W2553524991 cites W1972543205 @default.
• W2553524991 cites W1978198864 @default.
• W2553524991 cites W1980692842 @default.
• W2553524991 cites W1995305578 @default.
• W2553524991 cites W1995814266 @default.
• W2553524991 cites W2001167267 @default.
• W2553524991 cites W2001968948 @default.
• W2553524991 cites W2003209902 @default.
• W2553524991 cites W2020205776 @default.
• W2553524991 cites W2032734824 @default.
• W2553524991 cites W2037457588 @default.
• W2553524991 cites W2046899821 @default.
• W2553524991 cites W2062520454 @default.
• W2553524991 cites W2065193247 @default.
• W2553524991 cites W2066675802 @default.
• W2553524991 cites W2071180575 @default.
• W2553524991 cites W2071262537 @default.
• W2553524991 cites W2084927627 @default.
• W2553524991 cites W2085483866 @default.
• W2553524991 cites W2087787237 @default.
• W2553524991 cites W2087807343 @default.
• W2553524991 cites W2093700540 @default.
• W2553524991 cites W2101610989 @default.
• W2553524991 cites W2113709533 @default.
• W2553524991 cites W2116517714 @default.
• W2553524991 cites W2117322871 @default.
• W2553524991 cites W2134379330 @default.
• W2553524991 cites W2146895815 @default.
• W2553524991 cites W2161217162 @default.
• W2553524991 cites W2163328478 @default.
• W2553524991 cites W2190699142 @default.
• W2553524991 cites W2289053944 @default.
• W2553524991 cites W2320226321 @default.
• W2553524991 cites W2335757446 @default.
• W2553524991 cites W302624052 @default.
• W2553524991 cites W324286236 @default.
• W2553524991 cites W4211052952 @default.
• W2553524991 doi "https://doi.org/10.1016/j.ophtha.2016.10.001" @default.
• W2553524991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27863844" @default.
• W2553524991 hasPublicationYear "2017" @default.
• W2553524991 type Work @default.
• W2553524991 sameAs 2553524991 @default.
• W2553524991 citedByCount "27" @default.
• W2553524991 countsByYear W25535249912017 @default.
• W2553524991 countsByYear W25535249912018 @default.
• W2553524991 countsByYear W25535249912019 @default.
• W2553524991 countsByYear W25535249912020 @default.
• W2553524991 countsByYear W25535249912021 @default.
• W2553524991 countsByYear W25535249912022 @default.
• W2553524991 countsByYear W25535249912023 @default.
• W2553524991 crossrefType "journal-article" @default.
• W2553524991 hasAuthorship W2553524991A5020600237 @default.
• W2553524991 hasAuthorship W2553524991A5021915992 @default.
• W2553524991 hasAuthorship W2553524991A5028366362 @default.
• W2553524991 hasAuthorship W2553524991A5035292611 @default.
• W2553524991 hasAuthorship W2553524991A5052865753 @default.
• W2553524991 hasAuthorship W2553524991A5064803314 @default.
• W2553524991 hasBestOaLocation W25535249911 @default.
• W2553524991 hasConcept C118487528 @default.
• W2553524991 hasConcept C126322002 @default.
• W2553524991 hasConcept C159110408 @default.
• W2553524991 hasConcept C2778257484 @default.
• W2553524991 hasConcept C2778560704 @default.
• W2553524991 hasConcept C2779134260 @default.
• W2553524991 hasConcept C2779951463 @default.
• W2553524991 hasConcept C71924100 @default.
• W2553524991 hasConceptScore W2553524991C118487528 @default.
• W2553524991 hasConceptScore W2553524991C126322002 @default.
• W2553524991 hasConceptScore W2553524991C159110408 @default.
• W2553524991 hasConceptScore W2553524991C2778257484 @default.
• W2553524991 hasConceptScore W2553524991C2778560704 @default.
• W2553524991 hasConceptScore W2553524991C2779134260 @default.
• W2553524991 hasConceptScore W2553524991C2779951463 @default.
• W2553524991 hasConceptScore W2553524991C71924100 @default.
• W2553524991 hasIssue "2" @default.
• W2553524991 hasLocation W25535249911 @default.
• W2553524991 hasLocation W25535249912 @default.
• W2553524991 hasOpenAccess W2553524991 @default.
• W2553524991 hasPrimaryLocation W25535249911 @default.
• W2553524991 hasRelatedWork W2064128327 @default.
• W2553524991 hasRelatedWork W2074635175 @default.
• W2553524991 hasRelatedWork W2092472427 @default.
• W2553524991 hasRelatedWork W2135121307 @default.

• next